Сила цикла. Как использовать непостоянство гормонов, чтобы жить на полную

«До начала приема тестостерона месячные продолжались у меня от трех до пяти дней и сопровождались несколькими побочными эффектами. Однако после трех-четырех месяцев гормональной терапии месячные стали нерегулярными, длились до двух недель и сопровождались самыми сильными спазмами в моей жизни. Это продолжалось в течение шести месяцев приема тестостерона и не прекращалось, пока мне не пришлось прекратить гормональную терапию из-за проблем с финансами и страховкой»: Bliss, C. (2018) What trans and non-binary menstruators should know about periods, Seventeen, 1 June 2018. [Онлайн]. Доступно на: https://www.seventeen.com/health/a20963434/transand-non-binaryperiods/ [Дата обращения 20 июня 2018].

«Тот факт, что слизистая оболочка одного из ваших органов периодически отслаивается, не определяет, кто вы есть на самом деле и как мир видит вас… Месячные вас не определяют». Bliss, C. (2018) Там же.

Другие источники

Adeniji, A. A. et al (2016) Metabolic effects of a commonly used combined hormonal oral contraceptive in women with and without polycystic ovary syndrome, Journal of Women’s Health, 25(6), pp. 638–645.

Akin, M. et al (2004) Continuous, low-level, topical heat wrap therapy as compared to acetaminophen for primary dysmenorrhoea, Journal of Reproductive Medicine, 49(9), pp. 739–745.

Allahbadia, G. and Merchant, R. (2011) Polycystic ovary syndrome and impact on health, Middle East Fertility Society Journal, 16(1), pp. 19–37.

Asvold, B. O., Vatten, L. J. and Bjøro, T. (2013) Changes in the prevalence of hypothyroidism: the HUNT study in Norway, European Journal of Endocrinology, 169(5), pp. 613–620.

BMJ (2004) 328:1199.

Borsos, A. et al (1988) Ibid.

Bouaziz, J. et al (2017) The clinical significance of endocannabinoids in endometriosis pain management, Cannabis and cannabinoid research, 2(1), pp. 72–80.

Canaris, G. J. et al (2000) The Colorado thyroid disease prevalence study, Archives of Internal Medicine, 160(4), pp. 526–534.

Ciavattini, A. et al (2017) Ovarian endometriosis and vitamin D serum levels, Gynaecology Endocrinology, 33(2), pp. 164–167.

Dehnavi, Z. M., Jafarnejad, F. and Kamali, Z. (2018) The effect of aerobic exercise on primary dysmenorrhoea: a clinical trial study, Journal of Education and Health Promotion, 7(3).

Ding, T. et al (2017) The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis, Oncotarget, 8(56), pp. 96351–96358.

Dubet, N. et al (2016) The ESC/E(Z) complex, an intrinsic cellular molecular pathway differentially responsive to ovarian steroids in premenstrual dysphoric disorder, Molecular Psychiatry, 22(18), pp. 1172–1184.

Edlund, M. et al (1996) On the value of menorrhagia as a predictor for coagulation disorders, American Journal of Hematology, 53 (4), pp. 234–238. Kadir, R. A. et al (1998) Frequency of inherited bleeding disorders in women with menorrhagia, Lancet, 351(9101), pp. 485–489.

Falsetti, L. et al (2002) Long-term follow-up of functional hypothalamic amenorrhea and prognostic factors, Journal of Clinical Endocrinology Metabolism, 87(2), pp. 500–505.

Falsetti, L. et al (2002) Long-term follow-up of functional hypothalamic amenorrhea and prognostic factors, Journal of Clinical Endocrinology Metabolism, 87(2), pp. 500–505.

Grandi, G. et al (2012) Prevalence of menstrual pain in young women: what is dysmenorrhoea? Journal of Pain Research, 5, pp. 169–174.

Halme, J. et al (1984) Retrograde menstruation in healthy women and in patients with endometriosis, Obstetrics and Gynaecology, 64(2), pp. 151–154.

Hoffmann, D. E. and Tarzian, A. J. (2001) The girl who cried pain: A bias against women in the treatment of pain, The Journal of Law, Medicine and Ethics, 29(1), pp. 13–27.

Hubacher, D., Chen, P. L. and Park, S. (2009) Side effects from the copper IUD: do they decrease over time? Contraception, 79(5), pp. 356–362.

Huo, L. et al (2007) Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene, Biological Psychiatry, 62(8), pp. 925–933.

Jacobstein, R. and Polis, C. B. (2014) Progestin-only contraception: injectables and implants, Best Practice and Research. Clinical Obstetrics and Gynaecology, 28(6), pp. 795–806.

Keshavarzi, F. et al (2018) Both melatonin and meloxicam improved sleep and pain in females with primary dysmenorrhoea — results from a double-blind crossover intervention pilot study, Archives of Women’s Mental Health, 21(6), pp. 601–609.

Kessler, L. et al (2010) Changes in serum TSH and free T4 during human sleep restriction, Sleep, 33(8), pp. 1115–1118.